Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
CYTX > SEC Filings for CYTX > Form 8-K on 27-Feb-2013All Recent SEC Filings

Show all filings for CYTORI THERAPEUTICS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for CYTORI THERAPEUTICS, INC.

27-Feb-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On February 25, 2013, Cytori Therapeutics, Inc. ("Cytori") issued a press release announcing that it has received a CE Mark in Europe for Intravase®, a reagent intended to be used with Cytori's Celution® System for preparing safe and optimized adipose-derived stem and regenerative cells (ADRCs) for intravascular delivery into the same patient. Intravase® is a sterile, GMP-grade secondary reagent used with the Celution® System to prepare the Celution® cell output for safe intravascular delivery.

A copy of this press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description
99.1 Cytori Therapeutics, Inc. Press Release, dated February 25, 2013

  Add CYTX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CYTX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.